Ke Pan
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Natural product bioactivities and synthesis 8
- Plant Toxicity and Pharmacological Properties 4
- Ginseng Biological Effects and Applications 4
- Pharmacology 16
- Cholinesterase and Neurodegenerative Diseases 11
- Co-authors
- Zhi‐Qi Yin (23 shared papers)Jian‐Guang Luo (8 shared papers)Ling‐Yi Kong (7 shared papers)Zhong‐Bo Zhou (10 shared papers)Frank Jordan (2 shared papers)Jian Zhang (15 shared papers)Cuihua Jiang (8 shared papers)Jian‐Chuan Xia (7 shared papers)
- Journals
- Phytochemistry (6 papers)Phytomedicine (3 papers)Journal of Ethnopharmacology (3 papers)Fitoterapia (3 papers)Chinese Journal of Cancer (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Ke Pan
66 papers receiving 960 citations
Peers
Comparison fields: 5 of 92
- Pharmacology 178
- Pharmacology 61
- Complementary and alternative medicine 55
- Biochemistry 38
- Biochemistry 42
Countries citing papers authored by Ke Pan
This map shows the geographic impact of Ke Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Pan more than expected).
Fields of papers citing papers by Ke Pan
This network shows the impact of papers produced by Ke Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Pan. The network helps show where Ke Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ke Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 60 | |
| 2 | 2016 | 57 | |
| 3 | 2019 | 50 | |
| 4 | 2014 | 44 | |
| 5 | 2018 | 41 | |
| 6 | 2010 | 40 | |
| 7 | 2021 | 33 | |
| 8 | 2013 | 32 | |
| 9 | 2010 | 32 | |
| 10 | 2021 | 32 | |
| 11 | 2012 | 32 | |
| 12 | 1995 | 29 | |
| 13 | 1998 | 27 | |
| 14 | Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array. | 2010 | 24 |
| 15 | 2022 | 22 | |
| 16 | 2021 | 22 | |
| 17 | 2018 | 22 | |
| 18 | 2022 | 18 | |
| 19 | 2015 | 18 | |
| 20 | 2019 | 16 |
About Ke Pan
Ke Pan is a scholar working on Molecular Biology, Pharmacology, Plant Science, Organic Chemistry and Pharmacology, having authored 69 papers that have together received 966 indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (11 papers), Chemical synthesis and alkaloids (9 papers), Natural product bioactivities and synthesis (8 papers), Phytochemistry and Biological Activities (4 papers), Plant Toxicity and Pharmacological Properties (4 papers), Allelopathy and phytotoxic interactions (4 papers), Ginseng Biological Effects and Applications (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). The work is most often cited by research in Pharmacology (178 citations), Pharmacology (61 citations), Complementary and alternative medicine (55 citations), Biochemistry (38 citations) and Biochemistry (42 citations). Ke Pan has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Zhi‐Qi Yin, Jian‐Guang Luo, Ling‐Yi Kong, Zhong‐Bo Zhou, Frank Jordan, Jian Zhang, Cuihua Jiang, Jian‐Chuan Xia, Jing-Jing Zhao and Shan-Shan Jiang. Their work appears in journals such as Phytochemistry, Phytomedicine, Journal of Ethnopharmacology, Fitoterapia and Chinese Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.